FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

397179004: Nonoxinol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1776867016 Nonoxynol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2643023018 Nonoxinol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3670167010 Nonoxinol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
947881000195116 nonoxinol it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
36721000188110 Nonoxinol fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
672151000274118 Nonoxynol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
672161000274115 Nonoxinol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nonoxinol Is a agent divers false Inferred relationship Some
Nonoxinol Is a Polymer (substance) true Inferred relationship Some
Nonoxinol Is a agent pour l'appareil génital false Inferred relationship Some
Nonoxinol Is a Nonionic surfactant true Inferred relationship Some
Nonoxinol Is a agent contraceptif false Inferred relationship Some
Nonoxinol Is a spermicide false Inferred relationship Some
Nonoxinol This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Nonionic surfactant (disposition) true Inferred relationship Some
Nonoxinol Is a excipient pharmaceutique false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Nonoxinol 9 (substance) Is a False Nonoxinol Inferred relationship Some
Product containing nonoxinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nonoxinol Inferred relationship Some 1
Nonoxinol-9 6% pessary The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nonoxinol Inferred relationship Some
Nonoxinol adverse reaction Causative agent (attribute) True Nonoxinol Inferred relationship Some 1
Contraceptive sponge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nonoxinol Inferred relationship Some
Allergy to nonoxinol (finding) Causative agent (attribute) False Nonoxinol Inferred relationship Some
Nonoxinol 125 mg/g vaginal foam The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nonoxinol Inferred relationship Some
Nonoxinol 20 mg/g vaginal cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nonoxinol Inferred relationship Some
Product containing precisely nonoxinol 20 milligram/1 milliliter conventional release vaginal gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nonoxinol Inferred relationship Some
Nonoxinol '9' 5% pessary The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nonoxinol Inferred relationship Some
Nonoxynol 9 1g contraceptive sponge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nonoxinol Inferred relationship Some
Contraceptive sponge NOS The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nonoxinol Inferred relationship Some
Allergy to nonoxinol (finding) Causative agent (attribute) True Nonoxinol Inferred relationship Some 1
Nonoxinol 9 (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Nonoxinol Inferred relationship Some
Product containing nonoxinol in vaginal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nonoxinol Inferred relationship Some 1
Nonoxinol 125 mg/g vaginal foam The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nonoxinol Inferred relationship Some 1
Nonoxinol 125 mg/g vaginal foam This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nonoxinol Inferred relationship Some 1
Nonoxinol 20 mg/g vaginal cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nonoxinol Inferred relationship Some 1
Nonoxinol 20 mg/g vaginal cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nonoxinol Inferred relationship Some 1
Product containing precisely nonoxinol 20 milligram/1 milliliter conventional release vaginal gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nonoxinol Inferred relationship Some 1
Product containing precisely nonoxinol 20 milligram/1 milliliter conventional release vaginal gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nonoxinol Inferred relationship Some 1
Product containing only nonoxinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nonoxinol Inferred relationship Some 1
Nonoxinol only product in vaginal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nonoxinol Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

Back to Start